NEW APPROACH OF QUANTITATIVE NUCLEAR CARDIAC PERFUSION ASSESSMENT IN PATIENTS WITH PULMONARY HYPERTENSION
https://doi.org/10.20862/0042-4676-2016-97-6-340-347
Abstract
Objective: to develop and implement a new processing approach of myocardial perfusion images obtained by single-photon emission computed tomography (SPECT) in patients with pulmonary hypertension (PH). Material and methods. 18 patients with idiopathic pulmonary hypertension underwent gated rest-stress perfusion SPECT with 99mTc-MIBI with CT-attenuation correction. Images were processed manually, with separate reorientation and semi-automatic contouring of both ventricles. MIBI intensity ratio in the right and left ventricles (RV/LV) was calculated using novel volumetric method, in comparison with other described approaches. Results. In patients with PH myocardial perfusion SPECT revealed abnormal RV visualization, dilation and reduced contractility, paradoxical motion and typical perfusion defects of interventricular septum. RV contouring in semi-automatic mode was possible in 100% of cases. The average values of RV/LV ratio in PH patients and normal group was 0.6097 ± 0.0090 and 0.2750 ± 0.0355, respectively (p<0.001). Conclusion. The new method of quantitative calculation of perfusion impairments allows to reveal the features of myocardial perfusion of the right and left ventricles in patients with pulmonary hypertension, with the potential to assess therapy effectiveness in these patients.> <0.001). Conclusion. The new method of quantitative calculation of perfusion impairments allows to reveal the features of myocardial perfusion of the right and left ventricles in patients with pulmonary hypertension, with the potential to assess therapy effectiveness in these patients.
About the Authors
A. A. AnshelesRussian Federation
MD, PhD, Senior Researcher
E. G. Valeeva
Russian Federation
Postgraduate
T. V. Martynyuk
Russian Federation
MD, PhD, DSc, Head of Laboratory of Pulmonary Hypertension, Leading Researcher of Department of Hypertension
V. B. Sergienko
Russian Federation
MD, PhD, DSc, Professor, Head of Nuclear Medicine and Positron Emission Tomography Department
References
1. Galie N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 2016; 37 (1): 67–119.
2. Gargiulo P., Cuocolo A., Dellegrottaglie S., Prastaro M., Savarese G., Assante R. et al. Nuclear assessment of right ventricle. Echocardiography. 2015; 32 (Suppl. 1): S69–74.
3. Corbett J.R., Akinboboye O.O., Bacharach S.L., Borer J.S., Botvinick E.H., DePuey E.G. et al. Equilibrium radionuclide angiocardiography. J. Nucl. Cardiol. 2006; 13 (6): e56–79.
4. Verrier R.L., Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr. Opin. Cardiol. 2004. 19 (1): 2–11. PMCID: 1513619.
5. Matsushita T., Ikeda S., Miyahara Y., Yakabe K., Yamaguchi K., Furukawa K. et al. Use of [123I]- BMIPP myocardial scintigraphy for the clinical evaluation of a fattyacid metabolism disorder of the right ventricle in chronic respiratory and pulmonary vascular disease. J. Int. Med. Res. 2000; 28 (3): 111–23.
6. Bokhari S., Raina A., Rosenweig E.B., Schulze P.C., Bokhari J., Einstein A.J. et al. PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension. Circ. Cardiovasc. Imaging. 2011; 4 (6): 641–7.
7. Архипова О.А., Мартынюк Т.В., Валеева Э.Г., Рябыкина Г.В., Самойленко Л.Е., Сергиенко В.Б. Ишемия миокарда у пациентов с легочной артериальной гипертензией. Системные гипертензии. 2015; 4: 52–6. [Arkhipova O.A., Martynyuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B. Myocardial ischemia in patients with pulmonary arterial hypertension. Sistemnye Gipertenzii (Systemic Hypertension, Russian journal). 2015; 4: 52–6 (in Russ.).]
8. Vogel-Claussen J., Skrok J., Shehata M.L., Singh S., Sibley C.T., Boyce D.M. et al. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology. 2011; 258 (1): 119–27. PMCID: 3009386.
9. Сергиенко В.Б., Аншелес А.А. Томографические методы в оценке перфузии миокарда. Вестник рентгенологии и радиологии. 2010; 3: 10–4. [Sergienko V.B., Ansheles A.A. Tomographic methods in the assessment of myocardial perfusion. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2010; 3: 10–4 (in Russ.).]
10. Gomez A., Bialostozky D., Zajarias A., Santos E., Palomar A., Martinez M.L. et al. Right ventricular ischemia in patients with primary pulmonary hypertension. J. Am. Coll. Cardiol. 2001; 38 (4): 1137–42.
11. Ohira H., Beanlands R.S., Davies R.A., Mielniczuk L. The role of nuclear imaging in pulmonary hypertension. J. Nucl. Cardiol. 2015; 22 (1): 141–57.
12. Mazraeshahi R.M., Striet J., Oeltgen R.C., Gerson M.C. Myocardial SPECT images for diagnosis of pulmonary hypertension and right ventricular hypertrophy. J. Nucl. Med. Technol. 2010; 38 (4): 175–80.
13. Mannting F., Zabrodina Y.V., Dass C. Significance of increased right ventricular uptake on 99mTc-sestamibi SPECT in patients with coronary artery disease. J. Nucl. Med. 1999; 40 (6): 889–94.
14. Сергиенко В.Б., Аншелес А.А., Шульгин Д.Н., Иванов К.П., Миронов С.П. Методические реко- мендации: перфузионная сцинтиграфия и ОЭКТ миокарда. Кардиологический вестник. 2015; X (2): 6–21. [Sergienko V.B., Ansheles A.A., Shul’gin D.N., Ivanov K.P., Mironov S.P. Guidelines: myocardial perfusion scintigraphy and SPECT. Kardiologicheskiy Vestnik (Journal of Cardiology, Russian journal). 2015; X (2): 6–21 (in Russ.).]
15. Bossone E., Dellegrottaglie S., Patel S., Grunig E., D'Andrea A., Ferrara F. et al. Multimodality imaging in pulmonary hypertension. Can. J. Cardiol. 2015; 31 (4): 440–59.
16. Аншелес А.А. Особенности интерпретации перфузионной однофотонной эмиссионной компьютерной томографии миокарда с компьютерно-томографической коррекцией поглощения. Вестник рентгенологии и радиологии. 2014; 2: 5–20. [Ansheles A.A. Specific features of interpretation of myocardial perfusion single-photon emission computed tomography with computed tomographic absorption correction. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2014; 2: 5–20 (in Russ.).]
17. Maedera M.T., Stöcklib M., Zellweger M.J. Myocardial perfusion SPECT features of severe pulmonary artery hypertension. Kardiovaskuläre Medizin. 2007; 10: 113–4.
18. Gibbons Kroeker C.A., Adeeb S., Shrive N.G., Tyberg J.V. Compression induced by RV pressure overload decreases regional coronary blood flow in anesthetized dogs. Am. J. Physiol. Heart Circ. Physiol. 2006; 290 (6): H2432–8.
19. Oikawa M., Kagaya Y., Otani H., Sakuma M., Demachi J., Suzuki J. et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J. Am. Coll. Cardiol. 2005; 45 (11): 1849–55.
20. Аншелес А.А., Мартиросян Л.А., Сергиенко И.В., Сергиенко В.Б. Новые подходы к количественной оценке начальных нарушений и неоднородности перфузии миокарда по данным однофотонной эмиссионной компьютерной томографии. Вестник рентгенологии и радиологии. 2015; 5: 17–26. [Ansheles A.A., Martirosyan L.A., Sergienko I.V., Sergienko V.B. New approaches to quantifying early disorders and perfusion inhomogeneity of the myocardium according to the data of single-photon emission computed tomography. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2015; 5: 17–26 (in Russ.).]
Review
For citations:
Ansheles A.A., Valeeva E.G., Martynyuk T.V., Sergienko V.B. NEW APPROACH OF QUANTITATIVE NUCLEAR CARDIAC PERFUSION ASSESSMENT IN PATIENTS WITH PULMONARY HYPERTENSION. Journal of radiology and nuclear medicine. 2016;97(6):340-347. (In Russ.) https://doi.org/10.20862/0042-4676-2016-97-6-340-347